Lexeo Therapeutics, Inc. (LXEO)

Typically moves ±8.66% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-09 ESTIMATED

Lexeo Therapeutics, Inc. (LXEO) has reported earnings 12 times since Dec 11, 2023. The stock moves an average of ±8.66% the day after reporting, closing higher 66.7% of the time. Its largest post-earnings gain was +50.92% (Mar 24, 2025) and its largest decline was -12.94% (Dec 11, 2023). The next earnings report is predicted for 2026-11-09 (estimated).

Earnings reactions

How LXEO moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±8.66%

Positive %

66.7%

Negative %

33.3%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 12, 2026	☀ PRE	+1.67%	open_in_new
May 11, 2026	☀ PRE	+5.15%	open_in_new
Mar 30, 2026	☽ POST	+8.92%	open_in_new
Nov 05, 2025	☀ PRE	-1.8%	open_in_new
Aug 14, 2025	☀ PRE	+1.48%	open_in_new
May 12, 2025	☀ PRE	-2.23%	open_in_new
Mar 24, 2025	☀ PRE	+50.92%	open_in_new
Nov 13, 2024	☀ PRE	-0.65%	open_in_new
Aug 12, 2024	☀ PRE	+4.17%	open_in_new
May 09, 2024	☀ PRE	+5.69%	open_in_new
Mar 11, 2024	☽ POST	+8.28%	open_in_new
Dec 11, 2023	☀ PRE	-12.94%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±8.66%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 20 →

Funds holding

$102627474

Total value held

Buying

16 added · 4 reduced

Janus Henderson Group Plc

$28510358 NEW BUY

Blackrock, Inc.

$26717165 +12.30%

State Street Corp

$20271394 +22.04%

Goldman Sachs Group Inc

$10006444 +10.24%

Blackstone Inc.

$4217109 NEW BUY

SEC Filing Types

description SCHEDULE 13G/A

description SCHEDULE 13G

14 chevron_right

description SC 13G

9 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260819	open_in_new SEC.gov
4	20260819	open_in_new SEC.gov
4	20260819	open_in_new SEC.gov
144	20260818	open_in_new SEC.gov
144	20260818	open_in_new SEC.gov
144	20260818	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260813	open_in_new SEC.gov

Frequently asked about LXEO earnings

When does Lexeo Therapeutics, Inc. report earnings next? expand_more

Lexeo Therapeutics, Inc. (LXEO)'s next earnings date is estimated for 2026-11-09. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does LXEO stock move after earnings? expand_more

Over 12 reports, LXEO has moved an average of ±8.66% the session after earnings, closing higher 66.7% of the time.

What was LXEO's biggest post-earnings move? expand_more

LXEO's largest post-earnings gain on record was +50.92% on Mar 24, 2025, and its largest decline was -12.94% on Dec 11, 2023.

Where can I find Lexeo Therapeutics, Inc.'s SEC filings? expand_more

All of Lexeo Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.